Svetlana Bajalica-Lagercrantz

8PUBLICATIONS
27CO-AUTHORS
Cancer geneticsPredictive and prognostic markersNgā pūtaiao koiora-hauora, haumanu hoki o te Māori (Māori biomedical and clinical sciences)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 05, 2025
Characterisation of heritable TP53-related cancer syndrome in Sweden-a nationwide study of genotype-phenotype correlations in 90 families.

Meis Omran, Yaxuan Liu, Alexander Sun Zhang

|Oct 14, 2022
Pharmacogenomics for Prediction of Cardiovascular Toxicity: Landscape of Emerging Data in Breast Cancer Therapies.

Renske Altena, Svetlana Bajalica-Lagercrantz, Andri Papakonstantinou

|May 28, 2022
Whole-Exome Sequencing of Germline Variants in Non-BRCA Families with Hereditary Breast Cancer.

Yaxuan Liu, Hafdis T Helgadottir, Pedram Kharaziha

|Jan 21, 2022
Whole-Body MRI Surveillance-Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53).

Meis Omran, Emma Tham, Yvonne Brandberg

|Jul 02, 2021
Association between Predicted Effects of TP53 Missense Variants on Protein Conformation and Their Phenotypic Presentation as Li-Fraumeni Syndrome or Hereditary Breast Cancer.

Yaxuan Liu, Olga Axell, Tom van Leeuwen

|Jan 21, 2020
Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53.

Meis Omran, Lennart Blomqvist, Yvonne Brandberg

Pageof 2

Frequent Collaborators

3 joint publications

Meis Omran

3 joint publications

Emma Tham

2 joint publications

Yaxuan Liu

2 joint publications

Anna Rosén